Skip to content
Clinical Trials – home

Glucocorticoids: A Comprehensive Guide for Patients

0 / 1
trials open to patients / all trials
5+
Countries

In short

Glucocorticoids are a class of steroid hormones widely used in medical treatments for various inflammatory and autoimmune conditions. This article examines several clinical trials investigating the use of glucocorticoids for different health issues, including allergic bronchopulmonary aspergillosis, thyroid-associated ophthalmopathy, brain metastases, and more. These studies aim to evaluate the efficacy, safety, and optimal dosing of glucocorticoid treatments across various medical conditions.

At a glance

Conditions Studied
Allergic Bronchopulmonary Aspergillosis, Thyroid Associated Ophthalmopathy, Brain Metastases, Autoimmune Pancreatitis, Hypertension, Adrenal Insufficiency, Cushing Syndrome
Administration Methods
Oral tablets, Intravenous injections, Periorbital injections
Dosage Protocols
Varied by condition and study (e.g., 0.5-0.75 mg/kg/day for ABPA, 30mg/day for AIP)
Treatment Duration
Ranged from weeks to months, depending on the condition and study protocol
Combination Therapies
Glucocorticoids combined with immunotherapy, mycophenolate mofetil, cyclophosphamide in some studies
Primary Outcomes Measured
Disease remission rates, overall survival, changes in clinical activity scores, incidence of hypertension and other side effects
Potential Side Effects Studied
Hypertension, adrenal insufficiency, Cushing syndrome, immunosuppression

What Are Glucocorticoids?

Glucocorticoids are a class of steroid hormones that play a crucial role in regulating various bodily functions, including inflammation and immune responses. In medical treatments, synthetic versions of these hormones are used as powerful anti-inflammatory and immunosuppressive drugs. Common examples of glucocorticoids include prednisone, prednisolone, and methylprednisolone.

Conditions Treated with Glucocorticoids

Glucocorticoids are used to treat a wide range of conditions characterized by inflammation or immune system dysfunction. Some of the conditions mentioned in the clinical trials include:

  • Allergic Bronchopulmonary Aspergillosis (ABPA): A condition where the immune system overreacts to a fungus called Aspergillus, leading to lung inflammation.
  • Autoimmune Pancreatitis (AIP): An inflammatory condition of the pancreas caused by the body's immune system attacking its own tissues.
  • Thyroid Associated Ophthalmopathy (TAO): An eye condition related to thyroid disorders, causing inflammation and swelling of eye tissues.
  • Brain Metastases: Cancer that has spread to the brain from other parts of the body.
  • Chronic Inflammatory Diseases: Such as rheumatoid arthritis, lupus, and inflammatory bowel disease.
  • Paroxysmal Nocturnal Hemoglobinuria (PNH): A rare blood disorder that causes red blood cells to break down.
  • Idiopathic Retroperitoneal Fibrosis: A condition characterized by inflammation and fibrosis in the area behind the abdominal organs.

Administration Methods

Glucocorticoids can be administered through various routes, depending on the condition being treated and the specific drug formulation. The clinical trials mention several methods:

  • Oral: Taken by mouth in the form of tablets or liquids.
  • Intravenous (IV): Administered directly into the bloodstream.
  • Periorbital injection: Injected around the eye area for conditions like TAO.

Dosage and Treatment Protocols

The dosage and duration of glucocorticoid treatment vary widely depending on the condition being treated, its severity, and individual patient factors. Some examples from the clinical trials include:

  • For ABPA: Prednisolone 0.5 mg/kg/day for 2 weeks, then alternate days for 8 weeks, followed by gradual tapering.
  • For AIP: Prednisone starting at 0.6-0.8 mg/kg/day, then gradually tapered over several months.
  • For TAO: Periorbital injections every 3 weeks, with the number of injections determined by the patient's response.

It's crucial to follow your doctor's instructions precisely when taking glucocorticoids, as sudden discontinuation can be dangerous.

Efficacy and Benefits

Glucocorticoids are highly effective in managing various inflammatory and autoimmune conditions. They can provide rapid relief of symptoms and help control disease progression. Benefits observed in clinical trials include:

  • Reduction in inflammation and associated symptoms.
  • Improvement in organ function affected by inflammatory conditions.
  • Decreased disease activity in autoimmune disorders.
  • Management of symptoms related to cancer metastases.

Potential Side Effects and Risks

While glucocorticoids can be highly effective, they also come with potential side effects, especially with long-term use. Some of the risks mentioned in the clinical trials include:

  • Adrenal insufficiency: A condition where the body doesn't produce enough natural steroid hormones.
  • Cushing syndrome: A disorder caused by prolonged exposure to high levels of glucocorticoids.
  • Hypertension (high blood pressure).
  • Increased risk of infections due to suppressed immune function.
  • Bone loss and increased risk of fractures.

Ongoing Research and Clinical Trials

Researchers continue to study glucocorticoids to optimize their use and minimize side effects. Some areas of ongoing research include:

  • Comparing different dosing regimens to find the most effective and safest protocols.
  • Investigating the combination of glucocorticoids with other medications to enhance efficacy or reduce side effects.
  • Studying the long-term effects of glucocorticoid use in various conditions.
  • Exploring new administration methods and formulations.

These ongoing studies aim to improve our understanding of glucocorticoids and enhance their therapeutic use while minimizing potential risks.

Questions people often ask

Conditions where Glucocorticoids is being studied

Each condition opens its own overview and trial list

Trials with Glucocorticoids

Recruiting trials first

See all 1 →
Quick filters
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).